Table 2.
TyG index | Cases with endometriosis/N | OR (95% CI) | |||
---|---|---|---|---|---|
Crude a | Model 1 b | Model 2 c | Model 3 d | ||
Continuous Values
(7.049–11.951) |
135/1,590 | 1.52 (1.17–1.97)* | 1.53 (1.15–2.03)* | 1.73 (1.26–2.36)* | 1.62 (1.18–2.22)* |
Quartile Categories | |||||
Q1 (7.049–8.061) | 24/397 | Reference | Reference | Reference | Reference |
Q2 (8.063–8.452) | 31/398 | 1.31 (0.76–2.28) | 1.29 (0.74–2.25) | 1.35 (0.76–2.37) | 1.26 (0.71–2.23) |
Q3 (8.453–8.865) | 33/398 | 1.41 (0.81–2.42) | 1.35 (0.77–2.34) | 1.42 (0.81–2.51) | 1.31 (0.74–2.32) |
Q4 (8.866–11.951) | 47/397 | 2.09 (1.25–3.49)* | 1.99 (1.16–3.40)* | 2.27 (1.29–4.00)* | 2.04 (1.15–3.62)* |
P for trend | 0.004 | 0.010 | 0.004 | 0.013 |
*Statistically significant association.
Crude model was adjusted for nothing.
Model 1 was adjusted for age, ethnicity, education level and marital status.
Model 2 included the covariates of Model 1 with additional adjustment for diabetes, body mass index and fertility status.
Model 3 included the covariates of Model 2 with additional adjustment for drinking status, smoking status and use of oral contraceptives.
TyG index, triglyceride-glucose index; OR, odds ratio; CI, confidence interval.